<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-399-04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CEFUTIL 250MG F.C TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFUROXIME AXETIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Cefutil<sup>&reg;</sup></strong> is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, which is resistant to most &beta;(beta)-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms.</p><p dir="ltr">It is indicated for the treatment of infections caused by susceptible bacteria. Susceptibility to&nbsp; <strong>Cefutil<sup>&reg;</sup></strong> will vary with geography and time, and it should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data.</p><p dir="ltr"><strong>Indications include:</strong></p><p dir="ltr">Upper respiratory tract infections for example, ear, nose and throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis in adults and children over 12 years old.</p><p dir="ltr">Lower respiratory tract infections for example, pneumonia, acute exacerbations of chronic obstructive pulmonary disease in adults and children over 12 years old.</p><p dir="ltr">Genito-urinary tract infections (for example: pyelonephritis, cystitis and urethritis) in adults and children over 12 years old.</p><p dir="ltr">Skin and soft tissue infections (for example: furunculosis, pyoderma and impetigo) in adults and children over 12 years old.</p><p dir="ltr">Treatment of early Lyme disease and subsequent prevention of late Lyme disease in adults and children over 12 years old.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Do not take Cefutil<sup>&reg;</sup></strong>:</p><p dir="ltr">If you are&nbsp;allergic&nbsp;(hypersensitive)&nbsp;to antibiotics or any of the other ingredients of <strong>Cefutil<sup>&reg;</sup></strong>.</p><p dir="ltr">If you think this applies to you,&nbsp;don&rsquo;t take<sup>&nbsp;</sup><strong>Cefutil<sup>&reg; </sup></strong>until you have checked with your doctor.</p><p dir="ltr"><strong>Take special care with Cefutil</strong><sup>&reg;</sup></p><p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>is not recommended for children aged under 3 months, as it has not been adequately studied in this age group.</p><p dir="ltr"><strong>Look out for important symptoms</strong></p><p dir="ltr">Cefuroxime<strong> </strong>can cause serious side effects such as allergic reactions, fungal infections (such as candida) and severe diarrhoea (pseudomembranous colitis).&nbsp; You must look out for certain symptoms while you are taking <strong>Cefutil<sup>&reg;</sup></strong>, to reduce the risk of any problems.</p><p><strong>While you are taking Cefutil<sup>&reg;</sup></strong></p><p dir="ltr"><strong>If you need a blood test </strong></p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>can affect the results of a test for blood sugar levels, or a blood screen called the Coombs test. If you need a blood test: Tell the person taking the sample that you are taking <strong>Cefutil<sup>&reg;</sup></strong>.</p><p dir="ltr"><strong>Other medicines and Cefutil<sup>&reg;</sup></strong></p><p dir="ltr">Tell your doctor or pharmacist if you&rsquo;re taking any other medicines, if you&rsquo;ve taken any recently, or if you start taking new ones.&nbsp; This includes medicines bought without a prescription.</p><p dir="ltr">Medicines used to reduce the amount of acid in your stomach (e.g. antacids used to treat heartburn) can affect how <strong>Cefutil<sup>&reg;</sup> </strong>works.</p><p dir="ltr">Tell your doctor or pharmacist if you are taking any medicine like this.</p><p dir="ltr"><strong>Contraceptive pills </strong></p><p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>may reduce how well the contraceptive pill works. If you are taking the contraceptive pill while you are being treated with <strong>Cefutil<sup>&reg;</sup> </strong>you also need to use a barrier method of contraception (such as condoms). Ask your doctor for advice.</p><p dir="ltr"><strong>Pregnancy and breast-feeding </strong></p><p dir="ltr">There is only limited information about the safety of Cefuroxime<strong> </strong>in pregnant women.&nbsp;If you are pregnant&nbsp;your doctor will discuss with you if the benefits of taking <strong>Cefutil<sup>&reg; </sup></strong>outweigh the possible risks to your baby.</p><p dir="ltr">The ingredients in <strong>Cefutil<sup>&reg;</sup> </strong>can pass into breast milk.&nbsp;&nbsp;If you are breast-feeding, you must check with your doctor&nbsp;before you take <strong>Cefutil<sup>&reg;</sup></strong>.</p><p dir="ltr"><strong>Driving and using machines </strong></p><p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>can make you dizzy and have other side effects that make you less aler.</p><p dir="ltr">Don&rsquo;t drive or use machines unless you are feeling well.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p dir="ltr">If you have kidney problems your doctor may reduce your dose.</p><p dir="ltr"><strong>How much to take</strong></p><p dir="ltr"><strong>Adults</strong></p><p dir="ltr">The usual dose of <strong>Cefutil<sup>&reg;</sup> </strong>is 125&nbsp;mg to 1&nbsp;g per day depending on the severity and type of infection.</p><p><strong>Children</strong></p><p>The usual starting dose of <strong>Cefutil<sup>&reg;</sup> </strong>is 125&nbsp;mg to 500&nbsp;mg per day depending on the severity and type of infection.</p><p><strong>Cefutil<sup>&reg; </sup></strong>is not recommended for children aged under 3 months, as it has not been adequately studied in this age group.</p><p>Depending on the illness or how you or your child responds to treatment, the starting dose may be changed. More than one course of treatment may be needed.</p><p><strong>How to take/use</strong></p><p dir="ltr">Take <strong>Cefutil<sup>&reg;</sup> </strong>tablets after food.&nbsp;This will help to make the treatment more effective.</p><p dir="ltr">&nbsp;Swallow <strong>Cefutil<sup>&reg; </sup></strong>tablets whole with some water.</p><p dir="ltr">&nbsp;Don&rsquo;t chew, crush or split&nbsp;the tablets&nbsp;&mdash; This may make the treatment less effective.</p><p dir="ltr"><strong>If you forget to take Cefutil<sup>&reg;</sup></strong></p><p dir="ltr">Don&rsquo;t take an extra dose to make up for a missed dose. Just take your next dose at the usual time.</p><p dir="ltr"><strong>If you take too much Cefutil<sup>&reg;</sup></strong></p><p dir="ltr">If you take&nbsp;too much&nbsp;<strong>Cefutil<sup>&reg;</sup> </strong>you may be&nbsp;more likely to have fits&nbsp;(seizures).</p><p dir="ltr">Don&rsquo;t delay.&nbsp;Contact your doctor or your nearest hospital emergency department immediately. If possible, show them the <strong>Cefutil<sup>&reg; </sup></strong>pack.</p><p dir="ltr"><strong>Don&rsquo;t stop Cefutil<sup>&reg; </sup>without advice</strong></p><p dir="ltr">It is important that you take the full course of <strong>Cefutil<sup>&reg;</sup></strong>.&nbsp; Don&rsquo;t&nbsp;stop unless your doctor advises&nbsp;you to &ndash; even if you are feeling&nbsp;better. If you don&rsquo;t complete&nbsp;the full course of treatment, the&nbsp;infection may come back.</p><p dir="ltr">If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr"><strong>Look out for important symptoms</strong></p><p dir="ltr"><strong>Severe allergic reactions</strong></p><p dir="ltr">These are very rare in people taking <strong>Cefutil<sup>&reg;</sup></strong>. Signs include:</p><p dir="ltr">Raised and itchy rash (hives).</p><p dir="ltr">Swelling, sometimes of the face or mouth (angioedema), causing difficulty in breathing.</p><p dir="ltr">Collapse.</p><p dir="ltr">Contact a doctor immediately&nbsp;if you get any of these symptoms.</p><p dir="ltr"><strong>Serious skin reactions</strong></p><p dir="ltr">Skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge)&nbsp;erythema multiforme.</p><p dir="ltr">A widespread rash with blisters and skin peeling on much of the body surface&nbsp;(toxic epidermal necrolysis), particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome).</p><p dir="ltr">Contact a doctor immediately&nbsp;if you get these symptoms.</p><p><strong>Fungal infections</strong></p><p>On rare occasions, medicines like cefuroxime<strong> </strong>can cause an overgrowth of yeast (Candida) in the body which can lead to fungal infections (such as thrush). This side effect is more likely if you take cefuroxime<strong> </strong>for a long time.</p><p>Tell your doctor as soon as possible&nbsp;if you think you have a fungal infection. Your doctor may need to stop your treatment.</p><p><strong>Severe diarrhoea (Pseudomembranous colitis)</strong></p><p dir="ltr">On rare occasions, medicines like cefuroxime<strong> </strong>can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain, fever.</p><p dir="ltr">Tell your doctor as soon as possible&nbsp;if you get any of these symptoms.</p><p dir="ltr"><strong>Jarisch-Herxheimer reaction</strong></p><p dir="ltr">Some patients may get a high temperature (fever), chills, headache, muscle pain and skin rash while being treated with cefuroxime<strong> </strong>for Lyme disease. This is known as the&nbsp;Jarisch-Herxheimer reaction.&nbsp;Symptoms usually last a few hours or up to one day.</p><p dir="ltr">Tell your doctor immediately&nbsp;if you get any of these symptoms.</p><p dir="ltr"><strong>Common side effects</strong></p><p dir="ltr"><strong>These may affect up to 1 in 10 people:</strong></p><p dir="ltr">Fungal infections (such as candida).</p><p dir="ltr">Headache.</p><p dir="ltr">Dizziness.</p><p dir="ltr">Diarrhea.</p><p dir="ltr">Nausea (feeling sick).</p><p dir="ltr">Stomach pain.</p><p dir="ltr"><strong>Common side effects that may show up in blood tests:</strong></p><p dir="ltr">Increase in a type of white blood cell (eosinophilia).</p><p dir="ltr">Increase in some substances (enzymes) produced by the liver.</p><p dir="ltr"><strong>Uncommon side effects</strong></p><p dir="ltr"><strong>These may affect&nbsp;up to 1 in 100&nbsp;people:</strong></p><p dir="ltr">Vomiting.</p><p dir="ltr">Skin rashes.</p><p dir="ltr"><strong>Uncommon side effects that may show up in blood tests:</strong></p><p dir="ltr">Decrease in number of blood platelets (cells that help blood to clot) called&nbsp;thrombocytopenia.</p><p dir="ltr">Decrease in the number of white blood cells (leukopenia).</p><p dir="ltr"><strong>Rare side effects</strong></p><p dir="ltr"><strong>These may affect&nbsp;up to 1 in 1,000&nbsp;people:</strong></p><p dir="ltr">Severe diarrhoea (pseudomembranous colitis).</p><p dir="ltr"><strong>Very rare side effects</strong></p><p dir="ltr"><strong>These may affect&nbsp;up to 1 in 10,000&nbsp;people:</strong></p><p dir="ltr">Allergic reactions.</p><p dir="ltr">Severe skin reactions.</p><p dir="ltr">High temperature (fever).</p><p dir="ltr">Yellowing of the whites of the eyes or skin (jaundice).</p><p dir="ltr">Inflammation of the liver (hepatitis).</p><p dir="ltr"><strong>Very rare side effects that may show up in blood tests:</strong></p><p dir="ltr">Red blood cells destroyed too quickly (haemolytic anaemia).</p><p dir="ltr"><strong>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep out of the reach and sight of children.</p><p dir="ltr">Do not use <strong>Cefutil<sup>&reg;</sup> </strong>tablets after the expiry date (EXP) which is stated on the blister, label and the carton.</p><p dir="ltr">The expiry date refers to the last day of that month.</p><p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>tablets: Store below 30&deg;C.</p><p dir="ltr">Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The active substance is Cefuroxime (Axetil).</p><p dir="ltr">The other ingredients are microcrystalline cellulose, croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, colloidal anhydrous silica, magnesium stearate, opadry OY-L white, FD&amp;C Blue #1, PEG.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cefutil® 250 mg: blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in Alu/Alu blisters, intended for oral use.
Pack size: 10 film coated tablets.
Cefutil® 500 mg: blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in HDPE bottles, intended for oral use.
Pack size: 10 film coated tablets.
14 film coated tablets.
To report any side effect(s):
•Saudi Arabia:
The National Pharmacovigilance Center (NPC):
SFDA Call Center: 19999 
E-mail: npc.drug@sfda.gov.sa 
Website: https://ade.sfda.gov.sa
•United Arab of Emirates:
Pharmacovigilance and Medical Device Section
P.O. Box: 1853, Tel: 80033784
Email: pv@ede.gov.ae
Drug Department, Ministry of Health & Prevention
Dubai-UAE.
• Sultanate of Oman
Department of Pharmacovigilance & Drug Information
Drug Safety Center
Ministry of health, Sultanate of Oman
Phone No: 22357687 / 22357690
Fax : 22358489
Email : pharma-vigil@moh.gov.om
Website: www.moh.gov.om
•Other GCC States:
Please contact the relevant competent authority.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Pharma International Company</p><p dir="ltr">Amman - Jordan</p><p dir="ltr">Tel: 00962-6-5158890 / 5157893</p><p dir="ltr">Fax: 00962-6-5154753</p><p dir="ltr">Email: marketing@pic-jo.com</p><p dir="ltr">&nbsp;</p><p dir="ltr">This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised on 04/2025
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> هو دواء أولي للمضاد الحيوي سيفوروكسيم يتم تناوله عن طريق الفم وينتمي إلى مجموعة السيفالوسبورينات القاتلة للبكتيريا، و مقاوم لمعظم إنزيمات بيتا-لاكتاميز، وفعّال ضد مجموعة واسعة من الكائنات الحية موجبة وسالبة الجرام.</p><p dir="RTL">يتم وصفه لعلاج الالتهابات التي تسببها البكتيريا الحساسة. تختلف حساسية البكتيريا تجاه <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> حسب الموقع الجغرافي والوقت، لذلك يجب استعماله حسب الإرشادات المحلية الرسمية لوصف المضادات الحيوية وبيانات الحساسية المحلية.</p><p dir="RTL"><strong>تتضمن</strong><strong> </strong><strong>دواعي</strong><strong> </strong><strong>الاستعمال</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يلي</strong><strong>:</strong></p><p dir="RTL">التهابات الجهاز التنفسي العلوي، مثل الأذن، الأنف والحلق، مثل التهاب الأذن الوسطى، التهاب الجيوب الأنفية، التهاب اللوزتين، والتهاب البلعوم عند البالغين والأطفال الذين تزيد أعمارهم عن 12 عام.</p><p dir="RTL">التهابات الجهاز التنفسي السفلي، مثل الالتهاب الرئوي، التفاقم الحاد لمرض الانسداد الرئوي المزمن عند البالغين والأطفال الذين تزيد أعمارهم عن 12 عام..</p><p dir="RTL">التهابات الجهاز البولي التناسلي (مثل: التهاب الحويضة والكلية، التهاب المثانة، والتهاب الإحليل) عند البالغين والأطفال الذين تزيد أعمارهم عن 12 عام.</p><p dir="RTL">التهابات الجلد والأنسجة الرخوة (مثل: الدمامل، التقيحات الجلدية و القوباء) عند البالغين والأطفال الذين تزيد أعمارهم عن 12 عام.</p><p dir="RTL">علاج مرض لايم في مراحله المبكرة والوقاية من تطوره إلى المراحل المتأخرة عند البالغين والأطفال الذين تزيد أعمارهم عن 12 عام.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب</strong><strong> </strong><strong>عدم</strong><strong> </strong><strong>تناول</strong> <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>في</strong><strong> </strong><strong>الحالات</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL">إذا كنت تعاني من تحسس (فرط التحسس) للمضادات الحيوية أو لأي مكونات أخرى في<strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>.</p><p dir="RTL">إذا كنت تعتقد أن أي مما ذكر في الأعلى ينطبق عليك. لا تتناول <strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>إلى أن تتأكد من طبيبك.</p><p dir="RTL"><strong>الاحتياطات</strong><strong> </strong><strong>الخاصة</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">لا يوصى باستعمال <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> للأطفال الذين تقل أعمارهم عن 3 أشهر، وذلك لأنه لم يتم دراسته بشكل كافي في هذه الفئة العمرية.</p><p dir="RTL"><strong>يجب</strong><strong> </strong><strong>الانتباه</strong><strong> </strong><strong>لحدوث</strong><strong> </strong><strong>أعراض</strong><strong> </strong><strong>مهمة</strong></p><p dir="RTL">يمكن أن يسبب سيفوروكسيم<strong> </strong>&nbsp;آثار جانبية خطيرة مثل تفاعلات تحسسية، التهابات فطرية (مثل المبيضات) والإسهال الحاد (التهاب القولون الغشائي الكاذب). لذلك يجب الانتباه لأعراض معينة أثناء فترة تناول <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong>. هذا سيقلل خطر حدوث أي مشاكل.</p><p dir="RTL"><strong>أثناء</strong><strong> </strong><strong>فترة</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>بحاجة</strong><strong> </strong><strong>للخضوع</strong><strong> </strong><strong>لفحص</strong><strong> </strong><strong>دم</strong><strong> </strong></p><p dir="RTL">قد يؤثر <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> على نتائج فحص الدم المتعلقة بمستويات السكر في الدم، أو فحص الدم الذي يعرف بفحص كومبس. إذا كنت بحاجه للخضوع لفحص دم: أخبر الشخص الذي سيأخذ منك العينة بأنك تتناول <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong>.<strong> </strong></p><p dir="RTL"><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أي أدوية أخرى، إذا تناولت مؤخرا أو إذا كنت ستبدأ بتناول أدوية جديدة. هذا يتضمن الأدوية التي يتم الحصول عليها بدون وصفة طبية.</p><p dir="RTL">الأدوية التي تستعمل لتقليل كمية الحمض في المعدة (مثل مضادات الحموضة التي تستعمل لعلاج الحرقة) قد تؤثر على طريقة عمل <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أي دواء يشبه هذه الأدوية.</p><p dir="RTL"><strong>أقراص</strong><strong> </strong><strong>منع</strong><strong> </strong><strong>الحمل</strong><strong> </strong></p><p dir="RTL">قد يقلل <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> من فعالية أقراص منع الحمل. إذا كنت تتناولين أقراص منع الحمل خلال فترة العلاج باستعمال<strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> قد تحتاجين أيضا استعمال وسائل منع الحمل العازلة (مثل الواقي الذكري). استشيري طبيبك.</p><p dir="RTL"><strong>الحمل</strong><strong> </strong><strong>و</strong><strong> </strong><strong>الرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p dir="RTL">هناك معلومات محدودة فقط حول سلامة استعمال سيفوروكسيم للنساء الحوامل. إذا كنت حامل، سيناقش طبيبك معك إذا كانت فوائد تناول<strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>تفوق المخاطر المحتملة على طفلك.</p><p dir="RTL">يمكن أن تفرز مكونات <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> في حليب الثدي. إذا كنت مرضعة، يجب التأكد من طبيبك قبل تناول <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL"><strong>القيادة</strong><strong> </strong><strong>واستخدام</strong><strong> </strong><strong>الآلات</strong></p><p dir="RTL">قد يسبب <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> الشعور بالدوار وحصول آثار جانبية أخرى تقلل من الانتباه.</p><p dir="RTL">تجنب القيادة أو استعمال الآلات إلا إذا شعرت بأنك على ما يرام.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول هذا الدواء تماما كما أخبرك طبيبك أو الصيدلي. تأكد من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL">إذا كنت تعاني من مشاكل في الكلى، قد يقوم الطبيب بتقليل جرعتك.</p><p dir="RTL"><strong>الجرعة</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>يجب</strong><strong> </strong><strong>تناولها</strong></p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">تبلغ الجرعة المعتادة من <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> 125 ملغم إلى 1 غرام في اليوم اعتمادا على حدة الالتهاب ونوعه.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">تبلغ الجرعة الإبتدائية المعتادة من <strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>125 ملغم إلى 500 ملغم في اليوم اعتمادا على حدة الالتهاب ونوعه.</p><p dir="RTL">لا يوصى باستعمال <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong><strong> </strong>للأطفال الذين تقل أعمارهم عن 3 أشهر، وذلك لأنه لم يتم دراسته بشكل كافي في هذه الفئة العمرية.</p><p dir="RTL">قد تتغير الجرعة الابتدائية اعتمادا على نوع المرض أو كيفية استجابتك أو استجابة طفلك للعلاج. قد يكون هناك حاجة لتكرار العلاج.</p><p dir="RTL"><strong>كيفية</strong><strong> </strong><strong>تناول</strong><strong>/</strong><strong>استعمال</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">تناول <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong><strong> </strong>بعد تناول الطعام. هذا سيساعد في جعل العلاج أكثر فعالية.</p><p dir="RTL">قم بتناول أقراص <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> كاملة مع شرب بعض الماء.</p><p dir="RTL">تجنب مضغ، طحن أو تقسيم الأقراص - هذا قد يجعل العلاج أقل فعالية.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها. فقط تناول الجرعة التالية في وقتها المعتاد.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong><strong>&nbsp;</strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p dir="RTL">إذا تناولت <strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>أكثر مما يجب، قد تكون أكثر عرضة للاصابة بنوبات ظهور أعراض مفاجئة (نوبات صرع).</p><p dir="RTL">لا تتأخر. اتصل مع طبيبك أو قسم الطوارئ في أقرب مستشفى فورا. إذا أمكن، اصطحب معك عبوة <strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> ليراها الطبيب.</p><p dir="RTL"><strong>تجنب</strong><strong> </strong><strong>التوقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong><strong>بدون</strong><strong> </strong><strong>استشارة</strong><strong> </strong><strong>الطبيب</strong></p><p dir="RTL">من الضروري إكمال العلاج باستعمال<strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong>. لا تتوقف عن العلاج ما لم يخبرك الطبيب بذلك &ndash; حتى وإن شعرت بتحسن. إذا لم تكمل العلاج، قد يعود الالتهاب من جديد.</p><p dir="RTL">إذا كان لديك أي أسئلة إضافية عن استعمال هذا الدواء، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثار جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL"><strong>يجب</strong><strong> </strong><strong>الانتباه</strong><strong> </strong><strong>لحدوث</strong><strong> </strong><strong>أعراض</strong><strong> </strong><strong>مهمة</strong></p><p dir="RTL"><strong>تفاعل</strong><strong> </strong><strong>تحسسي</strong><strong> </strong><strong>حاد</strong></p><p dir="RTL">هذه الأعراض نادرة جدا عند الأشخاص الذين يتناولون<strong> </strong><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong><strong>،</strong><strong> </strong>الأعراض تتضمن ما يلي:</p><p dir="RTL">طفح بارز و يسبب الحكة (شرى).</p><p dir="RTL">تورم، أحيانا في الوجه أو الفم (وذمة وعائية)، مما يسبب صعوبة في التنفس.</p><p dir="RTL">وهط.</p><p dir="RTL">اتصل مع طبيبك فورا إذا عانيت من أي من هذه الأعراض.</p><p dir="RTL"><strong>تفاعل</strong><strong> </strong><strong>جلدي</strong><strong> </strong><strong>خطير</strong></p><p dir="RTL">طفح جلدي، الذي قد يكون على شكل تنفط (بثور)، ويظهر على شكل بقع صغيرة (بقع ذات مركز داكن محاطة بمنطقة أكثر شحوبا، مع ظهور حلقة داكنة على الأطراف) حمامي متعددة الأشكال.</p><p dir="RTL">طفح منتشر مع ظهور تنفط (بثور) و تقشير على معظم سطح الجلد (تحلل نخري سام في البشرة)، خصوصا، حول الفم، الأنف، العيون و الأعضاء التناسلية (متلازمة ستيڤن- جونسون).</p><p dir="RTL">اتصل مع طبيبك فورا إذا عانيت من أي من هذه الأعراض.</p><p dir="RTL"><strong>التهابات</strong><strong> </strong><strong>فطرية</strong></p><p dir="RTL">في حالات نادرة، قد تسبب الأدوية مثل سيفوروكسيم فرط نمو الخمائر (المبيضات) في الجسم الذي قد يؤدي إلى حدوث التهابات فطرية (مثل القلاع). هذا الأثر الجانبي أكثر شيوعا إذا كنت تتناول سيفوروكسيم<strong><sup> </sup></strong>لفترة طويلة.</p><p dir="RTL">أخبر طبيبك في أقرب وقت ممكن إذا كنت تعتقد بأنك تعاني من التهابات فطرية. قد يحتاج طبيبك إلى إيقاف علاجك.</p><p dir="RTL"><strong>إسهال</strong><strong> </strong><strong>حاد</strong><strong> (</strong><strong>التهاب</strong><strong> </strong><strong>القولون</strong><strong> </strong><strong>الغشائي</strong><strong> </strong><strong>الكاذب</strong><strong>)</strong></p><p dir="RTL">في حالات نادرة، قد تسبب الأدوية مثل سيفوروكسيم التهاب القولون (الأمعاء الغليظة)، مما يسبب حدوث إسهال، يرافقه عادة ظهور الدم والمخاط، ألم في المعدة، حمى.</p><p dir="RTL">أخبر طبيبك في أقرب وقت ممكن إذا عانيت من أي من هذه الأعراض.</p><p dir="RTL"><strong>تفاعل</strong><strong> </strong><strong>جاريش</strong><strong>-</strong><strong>هيكسهايمر</strong></p><p dir="RTL">قد يعاني بعض المرضى من ارتفاع درجة الحرارة (الحمى)، قشعريرة، صداع، ألم في العضلات وطفح جلدي خلال فترة تناول سيفوروكسيم لعلاج مرض لايم. وهذا يعرف بتفاعل جاريش هيكسهايمر. وتستمر الأعراض عادة ساعات قليلة أو لغاية يوم واحد.</p><p dir="RTL">أخبر طبيبك فورا إذا عانيت من أي من هذه الأعراض.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> </strong></p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>:</strong></p><p dir="RTL">التهابات فطرية (مثل المبيضات).</p><p dir="RTL">صداع.</p><p dir="RTL">الشعور بالدوار.</p><p dir="RTL">إسهال.</p><p dir="RTL">الشعور بالغثيان.</p><p dir="RTL">ألم في المعدة.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تظهر</strong><strong> </strong><strong>من</strong><strong> </strong><strong>خلال</strong><strong> </strong><strong>فحوصات</strong><strong> </strong><strong>الدم</strong><strong>:</strong></p><p dir="RTL">زيادة في عدد نوع من خلايا الدم البيضاء (زيادة الحمضات).</p><p dir="RTL">ارتفاع مستوى بعض المواد (إنزيمات)&nbsp; يتم إنتاجها في الكبد.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة</strong></p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">قيء.</p><p dir="RTL">طفح جلدي.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تظهر</strong><strong> </strong><strong>من</strong><strong> </strong><strong>خلال</strong><strong> </strong><strong>فحوصات</strong><strong> </strong><strong>الدم</strong><strong>:</strong></p><p dir="RTL">انخفاض في عدد الصفيحات الدموية (الخلايا التي تساعد في تجلط الدم).</p><p dir="RTL">انخفاض في عدد خلايا الدم البيضاء.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong></p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">إسهال حاد (التهاب القولون الغشائي الكاذب).</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدا</strong></p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">تفاعلات تحسسية.</p><p dir="RTL">تفاعلات جلدية حادة.</p><p dir="RTL">ارتفاع درجة حرارة الجسم (حمى).</p><p dir="RTL">اصفرار المنطقة البيضاء في العيون أو الجلد (يرقان).</p><p dir="RTL">التهاب الكبد.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدا</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تظهر</strong><strong> </strong><strong>من</strong><strong> </strong><strong>خلال</strong><strong> </strong><strong>فحوصات</strong><strong> </strong><strong>الدم</strong><strong>:</strong></p><p dir="RTL">تحطم خلايا الدم الحمراء بسرعة كبيرة (فقر الدم الانحلالي).</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>حصل</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية،</strong><strong> </strong><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>. </strong><strong>هذا</strong><strong> </strong><strong>يتضمن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>مذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول الأطفال و نظرهم.</p><p dir="RTL">لا تستعمل <strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong>بعد تاريخ انتهاء الصلاحية (EXP) المذكورعلى الشريط، الملصق و العلبة الخارجية.</p><p dir="RTL">تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL"><strong>سيفوتيل</strong><strong><sup>&reg;</sup></strong> أقراص: يحفظ في درجة حرارة دون 30 &deg;م.</p><p dir="RTL">يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي سيفوروكسيم (أكسيتيل).</p><p dir="RTL">المكونات الأخرى هي ميكروكريستالين سيليلوز، كروسكارميلوز صوديوم، جلايكوليت نشا الصوديوم، صوديوم لوريل سلفات، سيليكا غروية لا مائية، ستيرات المغنيسيوم، أوبادري OY-L أبيض، لون أزرق FD&amp;C رقم1، بولي إيثيلين جلايكول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong><strong>250 </strong><strong>ملغم</strong><strong>:</strong> هي أقراص مغلفة بيضاوية الشكل ذات لون أزرق، محدبة الوجهين، لا تحتوي على خط التقسيم، محفور على أحد الأوجه PhI، معبأة في أشرطة ألومنيوم/ألومنيوم، معدة للاستعمل عن طريق الفم.</p><p dir="RTL"><strong>حجم</strong><strong> </strong><strong>العبوة</strong><strong>:</strong> 10 أقراص مغلفة.</p><p dir="RTL"><strong>سيفوتيل</strong><strong><sup>&reg; </sup></strong><strong>500</strong> <strong>ملغم</strong><strong>:</strong> هي أقراص مغلفة بيضاوية الشكل ذات لون أزرق، محدبة الوجه، لا تحتوي على خط التقسيم، محفور على أحد الأوجه PhI، معبأة في زجاجة من بولي إيثيلين عالي الكثافة، معدة للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم</strong><strong> </strong><strong>العبوة</strong><strong>:</strong> 10 قرص مغلف.</p><p dir="RTL">14 قرص مغلف.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أعراض</strong><strong> </strong><strong>جانبية</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;&bull;</strong><strong>المملكة</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>السعودية</strong><strong>:</strong></p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الالكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>&bull;</strong><strong>الإمارات</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>المتحدة</strong><strong>:</strong></p><p dir="RTL">قسم اليقظة الدوائية والأجهزة الطبية</p><p dir="RTL">ص.ب: 1853، هاتف: 80033784</p><p dir="RTL">البريد الإلكتروني:&nbsp; pv@ede.gov.ae</p><p dir="RTL">قسم الأدوية، وزارة الصحة و وقاية المجتمع</p><p dir="RTL">دبي- الإمارات العربية المتحدة.</p><p dir="RTL"><strong>سلطنة</strong><strong> </strong><strong>عمان</strong></p><p dir="RTL">دائرة التيقظ و المعلومات الدوائية</p><p dir="RTL">مركز سلامة الدواء</p><p dir="RTL">وزارة الصحة، سلطنة عمان</p><p dir="RTL">هاتف: 0096822357687/0096822357690</p><p dir="RTL">فاكس: 0096822358489</p><p dir="RTL">البريد الالكتروني: pharma-vigil@moh.gov.om</p><p dir="RTL">الموقع الالكتروني: www.moh.gov.om</p><p dir="RTL"><strong>&bull; </strong><strong>دول</strong><strong> </strong><strong>الخليج</strong><strong> </strong><strong>العربي</strong><strong> </strong><strong>الأخرى</strong><strong>:</strong></p><p>الرجاء الاتصال بالجهات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة الدولية للدواء</p><p dir="RTL">عمان &ndash; الأردن</p><p dir="RTL">الهاتف: 5157893 / 5158890 - 6 - 00962&nbsp;</p><p dir="RTL">فاكس: 5154753 - 6 - 00962</p><p dir="RTL">البريد الإلكتروني: marketing@pic-jo.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 04/2025
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefutil® 250mg Film Coated Tablets. 
Cefutil® 500mg Film Coated Tablets.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefutil® 250mg Film Coated Tablets: each film coated tablet contains 250mg Cefuroxime axetil.
Cefutil® 500mg Film Coated Tablets: each film coated tablet contains 500mg Cefuroxime axetil.

Excipient: 
For a full list of excipients: see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefutil® 250 mg: blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in Alu/Alu blisters, intended for oral use.
Cefutil® 500 mg: blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in HDPE bottles, intended for oral use.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Cefutil<sup>&reg;</sup> </strong>is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, which is resistant to most (beta)-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms.&nbsp; It is indicated for the treatment of infections caused by susceptible bacteria. Susceptibility to <strong>Cefutil<sup>&reg;</sup> </strong>will vary with geography and time and local susceptibility data should be consulted where available (See Pharmacological properties, Pharmacodynamics).</p><p dir="ltr"><strong>Indications include:</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Upper respiratory tract infections for example, ear, nose and throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis in adults and children over 12 years old.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lower respiratory tract infections for example, pneumonia acute exacerbations of chronic obstructive pulmonary disease in adults and children over 12 years old.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Genito-urinary tract infections (for example: pyelonephritis, cystitis and urethritis) in adults and children over 12 years old.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and soft tissue infections (for example: furunculosis, pyoderma and impetigo) in adults and children over 12 years old.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of early Lyme disease and subsequent prevention of late Lyme disease in adults and children over 12 years old.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The usual course of therapy is seven days. (Range 5 to 10 days).</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Cefutil<sup>&reg; </sup></strong>should be taken after food for optimum absorption.</p><p dir="ltr"><strong>Adults</strong></p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>Most infections</p></td><td style="vertical-align:top"><p>&nbsp;250mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>Urinary tract infections</p></td><td style="vertical-align:top"><p>&nbsp;125mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>Mild to moderate lower respiratory tract infections e.g. bronchitis</p></td><td style="vertical-align:top"><p>&nbsp;250mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>More severe lower respiratory tract infections, or if pneumonia is suspected</p></td><td style="vertical-align:top"><p>500mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>Pyelonephritis</p></td><td style="vertical-align:top"><p>&nbsp;250mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>Uncomplicated gonorrhoea</p></td><td style="vertical-align:top"><p>&nbsp;single dose of 1g</p></td></tr><tr><td style="vertical-align:top"><p>Lyme disease in adults and children over the age of 12 years.</p></td><td style="vertical-align:top"><p>&nbsp;500mg twice daily for 20 days</p></td></tr></tbody></table><p dir="ltr"><strong>&nbsp;Sequential therapy</strong></p><p dir="ltr"><strong>Pneumonia</strong></p><p dir="ltr">1.5&nbsp;g cefuroxime Sodium three times a day or twice a day (intravenous (i.v.) or intramuscular (i.m)) for 48 to 72 hours, followed by&nbsp;<strong>Cefutil<sup>&reg;</sup></strong> (cefuroxime axetil) oral therapy 500&nbsp;mg twice a day for 7 to 10 days.</p><p dir="ltr"><strong>Acute exacerbations of chronic bronchitis</strong></p><p dir="ltr">750 mg&nbsp;cefuroxime Sodium three times a day or twice a day (iv or im) for 48 to 72 hours, followed by&nbsp;<strong>Cefutil<sup>&reg;</sup></strong> (cefuroxime axetil) oral therapy 500mg twice a day for 5 to 10 days.</p><p dir="ltr">Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children</strong></p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>Most infections</p></td><td style="vertical-align:top"><p>125mg (1 x 125mg tablet) twice daily, to a</p><p>maximum of 250mg daily.</p></td></tr><tr><td style="vertical-align:top"><p>Children aged two years or older with otitis media or, where appropriate, with more severe infections</p></td><td style="vertical-align:top"><p>250mg (1 x 250mg tablet or 2 x 125mg tablets) twice daily, to a maximum of 500mg daily.</p></td></tr></tbody></table><p dir="ltr"><strong>Cefutil<sup>&reg; </sup></strong>tablets should not be crushed and are therefore unsuitable for treatment of patients, such as younger children, who cannot swallow tablets. In children&nbsp;Cefuroxime oral suspension may be used.</p><p dir="ltr">There is no experience of using&nbsp;cefuroxime in children under the age of 3 months.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Renal impairment</strong></p><p dir="ltr">Cefuroxime is primarily excreted by the kidneys. In patients with markedly impaired renal function it is recommended that the dosage of cefuroxime be reduced to compensate for its slower excretion (see the table below).</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p><strong>Creatinine Clearance</strong></p></td><td style="vertical-align:top"><p><strong>T&nbsp;R1/2R&nbsp;(hours)</strong></p></td><td style="vertical-align:top"><p><strong>Recommended Dosage</strong></p></td></tr><tr><td style="vertical-align:top"><p>&ge;30 ml/min&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="vertical-align:top"><p>1.4 - 2.4</p></td><td style="vertical-align:top"><p>No dose adjustment necessary standard dose of 125 mg to 500 mg given twice daily</p></td></tr><tr><td style="vertical-align:top"><p>10-29 ml/min</p></td><td style="vertical-align:top"><p>4.6</p></td><td style="vertical-align:top"><p>Standard individual dose given every 24&nbsp;hours</p></td></tr><tr><td style="vertical-align:top"><p>&lt;10 ml/min</p></td><td style="vertical-align:top"><p>16.8</p></td><td style="vertical-align:top"><p>Standard individual dose given every 48&nbsp;hours</p></td></tr><tr><td style="vertical-align:top"><p>During haemodialysis</p></td><td style="vertical-align:top"><p>2 &ndash; 4</p></td><td style="vertical-align:top"><p>A single additional standard individual dose should be given at the end of each dialysis</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Patients with known hypersensitivity to cephalosporin antibiotics.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Special care is indicated in patients who have experienced an allergic reaction to penicillins or other beta-lactams.</p><p dir="ltr">As with other antibiotics, use of&nbsp;<strong>Cefutil<sup>&reg;</sup></strong> may result in the overgrowth of Candida. Prolonged use may also result in the overgrowth of other non-susceptible organisms (e.g. enterococci and&nbsp;Clostridium difficile), which may require interruption of treatment.</p><p dir="ltr">Pseudomembranous colitis has been reported with the use of antibiotics&nbsp;and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use.&nbsp;If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p dir="ltr">The Jarisch-Herxheimer reaction has been seen following&nbsp;cefuroxime&nbsp;treatment of Lyme disease.&nbsp; It results directly from the bactericidal activity of&nbsp;cefuroxime&nbsp;on the causative organism of Lyme disease, the spirochaete&nbsp;Borrelia burgdorferi.&nbsp; Patients should be reassured that this is a common and usually self-limiting consequence of antibiotic treatment of Lyme disease.</p><p dir="ltr">With a sequential therapy regime the timing of change to oral therapy is determined by severity of the infection, clinical status of the patient and susceptibility of the pathogens involved. If there is no clinical improvement within 72 hours, then the parenteral course of treatment must be continued.</p><p dir="ltr">Please refer to the relevant prescribing information for cefuroxime sodium before initiating sequential therapy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Drugs which reduce gastric acidity may result in a lower bioavailability of&nbsp;cefuroxime&nbsp;compared with that of the fasting state and tend to cancel the effect of enhanced post-prandial absorption.</p><p dir="ltr">In common with other antibiotics,&nbsp;cefuroxime&nbsp;may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p dir="ltr">As a false negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving&nbsp;cefuroxime.&nbsp; This antibiotic does not interfere in the alkaline picrate assay for creatinine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">There is no experimental evidence of embryopathic or teratogenic effects attributable to&nbsp;cefuroxime but, as with all drugs, it should be administered with caution during the early months of pregnancy.&nbsp;</p><p dir="ltr">Cefuroxime&nbsp;is excreted in human milk, and consequently caution should be exercised when&nbsp;cefuroxime is administered to a nursing mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">As this medicine may cause dizziness, patients should be warned to be cautious when driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Adverse drug reactions to&nbsp;cefuroxime&nbsp; are generally mild and transient in nature.</p><p dir="ltr">The frequency categories assigned to the adverse reactions below are estimates, as for most reactions suitable data (for example from placebo-controlled studies) for calculating incidence were not available.&nbsp;&nbsp;In addition,&nbsp;the incidence of adverse reactions associated with&nbsp;cefuroxime&nbsp;&nbsp;may vary according to the indication.</p><p dir="ltr">Data from large clinical studies were used to determine the frequency of very common to rare undesirable effects.&nbsp; The frequencies assigned to all other undesirable effects (i.e. those occurring at &lt;1/1000) were mainly determined using post-marketing data and refer to a reporting rate rather than true frequency.&nbsp; Placebo-controlled trial data were not available.&nbsp; Where incidences have been calculated from clinical trial data, these were based on drug-related (investigator assessed) data.</p><p dir="ltr">The following convention has been used for the classification of frequency:</p><p dir="ltr">&nbsp;Very common &ge;1/10</p><p dir="ltr">Common &ge;1/100&nbsp;to&nbsp;&lt;1/10</p><p dir="ltr">Uncommon &ge;1/1000&nbsp;to&nbsp;&lt;1/100</p><p dir="ltr">Rare &ge;1/10,000&nbsp;to&nbsp;&lt;1/1000</p><p dir="ltr">Very rare &lt;1/10,000</p><p dir="ltr"><strong>Infections and infestations</strong></p><p dir="ltr"><strong>Common:</strong>&nbsp;Overgrowth of Candida.</p><p dir="ltr"><strong>Blood and lymphatic system disorders</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="ltr"><strong>Common:</strong>&nbsp; Eosinophilia.</p><p dir="ltr"><strong>Uncommon:</strong> Positive Coombs&rsquo; test, thrombocytopenia, leucopenia (sometimes profound).</p><p dir="ltr"><strong>Very rare:</strong> Haemolytic anaemia.</p><p dir="ltr">Cephalosporins as a class tend to be absorbed onto the surface of red cells membranes and react with antibodies directed against the drug to produce a positive Coombs&rsquo; test (which can interfere with cross-matching of blood) and very rarely haemolytic anaemia.</p><p dir="ltr"><strong>Immune system disorders</strong></p><p dir="ltr"><strong>Hypersensitivity reactions including:</strong></p><p dir="ltr"><strong>Uncommon:</strong> Skin rashes.</p><p dir="ltr"><strong>Rare:</strong>&nbsp; Urticaria, pruritus.</p><p dir="ltr"><strong>Very rare:</strong> Drug fever, serum sickness, anaphylaxis.</p><p dir="ltr"><strong>Nervous system disorders</strong></p><p dir="ltr"><strong>Common:</strong> Headache, dizziness.</p><p dir="ltr"><strong>Gastrointestinal disorders</strong></p><p dir="ltr"><strong>Common:</strong> Gastrointestinal disturbances including diarrhoea, nausea, abdominal pain.</p><p dir="ltr"><strong>Uncommon:</strong> Vomiting.</p><p dir="ltr"><strong>Rare:</strong> Pseudomembranous colitis&nbsp;(See Warnings and Precautions).</p><p dir="ltr"><strong>Hepatobiliary disorders</strong></p><p dir="ltr"><strong>Common:&nbsp;</strong>Transient increases of hepatic enzyme levels, [ALT (SGPT), AST (SGOT), LDH].</p><p dir="ltr"><strong>Very rare:</strong> Jaundice (predominantly cholestatic), hepatitis.</p><p dir="ltr"><strong>Skin and subcutaneous tissue disorders</strong></p><p dir="ltr"><strong>Very rare:</strong>&nbsp; Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (exanthematic necrolysis).</p><p dir="ltr">See also Immune system disorders.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>To report any side effect(s):</strong></p><p dir="ltr"><strong>&bull;Saudi Arabia:</strong></p><p dir="ltr">The National Pharmacovigilance Center (NPC):</p><p dir="ltr">SFDA Call Center: 19999</p><p dir="ltr">E-mail: npc.drug@sfda.gov.sa</p><p dir="ltr">Website: https://ade.sfda.gov.sa</p><p dir="ltr"><strong>&bull;United Arab of Emirates:</strong></p><p dir="ltr">Pharmacovigilance and Medical Device Section</p><p dir="ltr">P.O. Box: 1853, Tel: 80033784</p><p dir="ltr">Email: pv@ede.gov.ae</p><p dir="ltr">Drug Department, Ministry of Health &amp; Prevention</p><p dir="ltr">Dubai-UAE.</p><p dir="ltr"><strong>&bull; Sultanate of Oman</strong></p><p dir="ltr">Department of Pharmacovigilance &amp; Drug Information</p><p dir="ltr">Drug Safety Center</p><p dir="ltr">Ministry of health, Sultanate of Oman</p><p dir="ltr">Phone No: 22357687 / 22357690</p><p dir="ltr">Fax: 22358489</p><p dir="ltr">Email: pharma-vigil@moh.gov.om</p><p dir="ltr">Website: www.moh.gov.om</p><p dir="ltr"><strong>&bull;Other GCC States:</strong></p><p dir="ltr">Please contact the relevant competent authority.</p><p dir="ltr" style="margin-left:20.7pt; margin-right:239.75pt; text-align:left"><br />&nbsp;</p><p style="margin-left:20.7pt; text-align:left">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Signs and symptoms</strong></p><p dir="ltr">Overdosage of cephalosporins can cause cerebral irritation leading to convulsions.</p><p dir="ltr"><strong>Treatment</strong></p><p dir="ltr">Serum levels of cefuroxime can be reduced by haemodialysis and peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:20.7pt; margin-right:51.55pt; text-align:left">&nbsp;</p><p dir="ltr">The prevalence of acquired resistance is geographically and time dependent and for select species may be very high.&nbsp; Local information on resistance is desirable, particularly when treating severe infections.</p><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="ltr">In vitro susceptibility of micro-organisms to Cefuroxime</p><p dir="ltr">&nbsp;</p><p dir="ltr">Where clinical efficacy of cefuroxime axetil has been demonstrated in clinical trials this is indicated with an asterisk (*).</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Commonly Susceptible Species</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Aerobes:</p><p dir="ltr">Staphylococcus aureus (methicillin susceptible)*</p><p dir="ltr">Coagulase negative staphylococcus (methicillin susceptible)</p><p dir="ltr">Streptococcus pyogenes*</p><p dir="ltr">Beta-hemolytic streptococci</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Negative Aerobes:</p><p dir="ltr">Haemophilus influenzae*&nbsp;including ampicillin resistant strains</p><p dir="ltr">Haemophilus parainfluenzae*</p><p dir="ltr">Moraxella catarrhalis*</p><p dir="ltr">Neisseria gonorrhoea*&nbsp;including penicillinase and non-penicillinase producing strains</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Anaerobes:</p><p dir="ltr">Peptostreptococcus spp.</p><p dir="ltr">Propionibacterium spp.</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Spirochetes:</p><p dir="ltr">Borrelia burgdorferi*</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Organisms for which acquired resistance may be a problem</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Aerobes:</p><p dir="ltr">Streptococcus pneumoniae*&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Negative Aerobes:</p><p dir="ltr">Citrobacter spp. not including C. freundii</p><p dir="ltr">Enterobacter spp. not including E. aerogenes and E. cloacae</p><p dir="ltr">Escherichia coli*</p><p dir="ltr">Klebsiella spp.&nbsp;including Klebsiella pneumoniae*</p><p dir="ltr">Proteus mirabilis</p><p dir="ltr">Proteus spp. not including P. penneri and P. vulgaris</p><p dir="ltr">Providencia&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Anaerobes:</p><p dir="ltr">Clostridium spp.&nbsp;not including C. difficile</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Negative Anaerobes:</p><p dir="ltr">Bacteroides spp. not including B. fragilis</p><p dir="ltr">Fusobacterium spp.</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Inherently resistant organisms</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Aerobes:</p><p dir="ltr">Enterococcus spp. including E. faecalis and E. faecium</p><p dir="ltr">Listeria monocytogenes</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Negative Aerobes:</p><p dir="ltr">Acinetobacter spp.</p><p dir="ltr">Burkholderia cepacia</p><p dir="ltr">Campylobacter spp.</p><p dir="ltr">Citrobacter freundii</p><p dir="ltr">Enterobacter aerogenes</p><p dir="ltr">Enterobacter cloacae</p><p dir="ltr">Morganella morganii</p><p dir="ltr">Proteus penneri</p><p dir="ltr">Proteus vulgaris&nbsp;</p><p dir="ltr">Pseudomonas&nbsp;spp. including Pseudomonas aeruginosa</p><p dir="ltr">Serratia spp.</p><p dir="ltr">Stenotrophomonas maltophilia</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Positive Anaerobes:</p><p dir="ltr">Clostridium difficile</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Gram-Negative Anaerobes:</p><p dir="ltr">Bacteroides fragilis</p></td></tr><tr><td style="vertical-align:top"><p dir="ltr">Others:</p><p dir="ltr">Chlamydia&nbsp;species</p><p dir="ltr">Mycoplasma&nbsp;species</p><p dir="ltr">Legionella&nbsp;species</p></td></tr></tbody></table><p dir="ltr" style="text-align:left">&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:22%"><tbody><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p dir="ltr"><strong>Absorption</strong></p><p dir="ltr">After oral administration cefuroxime&nbsp;is slowly absorbed from the gastrointestinal tract and rapidly hydrolysed in the intestinal mucosa and blood to release cefuroxime into the circulation.</p><p dir="ltr">Optimum absorption occurs when it is administered shortly after a meal.</p><p dir="ltr">Following administration of cefuroxime&nbsp; tablets peak serum levels (2.1&nbsp;mg/l for a 125&nbsp;mg dose, 4.S-S1&nbsp;mg/l for a 250&nbsp;mg dose,&nbsp;7.0&nbsp;mg/l for a 500&nbsp;mg dose and&nbsp;13.6&nbsp;mg/l for a 1&nbsp;g dose) occur approximately&nbsp;2 to 3&nbsp;hours after dosing when taken&nbsp;withfood.</p><p dir="ltr"><strong>Distribution</strong></p><p dir="ltr">Protein binding has been variously stated as 33-50% depending on the methodology used.</p><p dir="ltr"><strong>Metabolism</strong></p><p dir="ltr">Cefuroxime is not metabolised.</p><p dir="ltr"><strong>Elimination</strong></p><p dir="ltr">The serum half life is between 1 and 1.5 hours.</p><p dir="ltr">Cefuroxime is excreted by glomerular filtration and tubular secretion. Concurrent administration of probenecid increases the area under the mean serum concentrations time curve by 50%.</p><p dir="ltr"><strong>Renal impairment:</strong></p><p dir="ltr">Cefuroxime pharmacokinetics have been investigated in patients with various degrees of renal impairment.&nbsp; Cefuroxime elimination half-life increases with decrease in renal function which serves as the basis for dosage adjustment recommendations in this group of patients (See Dosage and Administration).&nbsp; In patients undergoing haemodialysis, at least 60% of the total amount of cefuroxime present in the body at the start of dialysis will be removed during a 4-hour dialysis period.&nbsp;&nbsp; Therefore, an additional single dose of cefuroxime should be administered following the completion of haemodialysis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr" style="margin-left:20.7pt; margin-right:36.55pt; text-align:left">Animal toxicity studies indicated that cefuroxime axetil is of low toxicity with no significant findings.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Microcrystalline cellulose, croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, Silica Colloidal Anhydrous, magnesium stearate, opadry OY-L white, FD&amp;C Blue #1, PEG.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                250mg: 4 years.
500 mg: 3 years.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Store below 30<sup>o</sup>C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Cefutil<sup>&reg;</sup> 250 mg:</strong> blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in Alu/Alu blisters, intended for oral use.</p><p dir="ltr"><strong>Pack size:</strong> 10 film coated tablets.</p><p dir="ltr"><strong>Cefutil<sup>&reg; </sup>500 mg:</strong> blue, oval, film coated, deep convex, non-scored tablets, engraved with PhI on one face, presented in HDPE bottles, intended for oral use.</p><p dir="ltr"><strong>Pack size:</strong> 10 film coated tablets.</p><p dir="ltr">14 film coated tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:15.3pt; margin-right:0cm; text-align:left">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma International Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893 
Fax: 00962-6-5154753
email: marketing@pic-jo.com



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04/2025
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>